GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » Cyclically Adjusted PS Ratio

DexCom (WBO:DXCM) Cyclically Adjusted PS Ratio : 13.47 (As of Jun. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is DexCom Cyclically Adjusted PS Ratio?

As of today (2025-06-24), DexCom's current share price is €69.50. DexCom's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €5.16. DexCom's Cyclically Adjusted PS Ratio for today is 13.47.

The historical rank and industry rank for DexCom's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:DXCM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 10.55   Med: 32.76   Max: 71.43
Current: 14.08

During the past years, DexCom's highest Cyclically Adjusted PS Ratio was 71.43. The lowest was 10.55. And the median was 32.76.

WBO:DXCM's Cyclically Adjusted PS Ratio is ranked worse than
93.35% of 481 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs WBO:DXCM: 14.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DexCom's adjusted revenue per share data for the three months ended in Mar. 2025 was €2.352. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €5.16 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


DexCom Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DexCom's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Cyclically Adjusted PS Ratio Chart

DexCom Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.71 50.32 32.52 28.31 14.46

DexCom Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.74 23.11 13.05 14.46 12.04

Competitive Comparison of DexCom's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, DexCom's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DexCom's Cyclically Adjusted PS Ratio falls into.


;
;

DexCom Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DexCom's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=69.50/5.16
=13.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, DexCom's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.352/134.9266*134.9266
=2.352

Current CPI (Mar. 2025) = 134.9266.

DexCom Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.261 100.684 0.350
201509 0.291 100.392 0.391
201512 0.368 99.792 0.498
201603 0.318 100.470 0.427
201606 0.365 101.688 0.484
201609 0.394 101.861 0.522
201612 0.480 101.863 0.636
201703 0.390 102.862 0.512
201706 0.434 103.349 0.567
201709 0.447 104.136 0.579
201712 0.537 104.011 0.697
201803 0.428 105.290 0.548
201806 0.580 106.317 0.736
201809 0.633 106.507 0.802
201812 0.836 105.998 1.064
201903 0.687 107.251 0.864
201906 0.817 108.070 1.020
201909 0.973 108.329 1.212
201912 1.125 108.420 1.400
202003 0.974 108.902 1.207
202006 1.034 108.767 1.283
202009 1.069 109.815 1.313
202012 1.177 109.897 1.445
202103 1.014 111.754 1.224
202106 1.156 114.631 1.361
202109 1.284 115.734 1.497
202112 1.432 117.630 1.643
202203 1.332 121.301 1.482
202206 1.563 125.017 1.687
202209 1.825 125.227 1.966
202212 1.806 125.222 1.946
202303 1.655 127.348 1.753
202306 1.864 128.729 1.954
202309 2.141 129.860 2.225
202312 2.274 129.419 2.371
202403 2.033 131.776 2.082
202406 2.238 132.554 2.278
202409 2.184 133.029 2.215
202412 2.615 133.157 2.650
202503 2.352 134.927 2.352

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DexCom  (WBO:DXCM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DexCom Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DexCom's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.